Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders

Blood

Volumn 97, Issue 7, 2001, Pages 2173-2176

  Aoki, Yoshiyasu ^a   Yarchoan, Robert ^b   Wyvill, Kathleen ^b   Okamoto, Shin Ichiro ^b   Little, Richard F ^b   Tosato, Giovanna ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; HERPES VIRUS; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; PATHOGENESIS; PRIORITY JOURNAL; UNITED STATES;

EID: 0035312975     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.7.2173     Document Type: Article

References (25)

1. Current perspectives on the molecular pathogenesis of virus-induced cancers in human immunodeficiency virus infection and acquired immunodeficiency syndrome
2. AIDS-related malignancies
3. Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6
4. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV
5. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6
6. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells
7. Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells
8. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6
9. Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas
10. Detection of vascular endothelial growth factor in AIDS-related primary effusion lymphomas
11. Human immunodeficiency virus tat modulates the Flk-1/KDR receptor, mitogen-activated protein kinases, and components of focal adhesion in Kaposi's sarcoma cells
12. c-Src mediates mitogenic signals and associates with cytoskeletal proteins upon vascular endothelial growth factor stimulation in Kaposi's sarcoma cells
13. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease
14. Viral and cellular cytokines in AIDS-related malignant lymphomatous effusions
15. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease
16. Heterogeneity of viral IL-6 expression in HHV-8-associated diseases
17. AIDS-related Kaposi's sarcoma: Prospective validation of the AIDS Clinical Trials Group staging classification
18. Interassay correlation of human herpesvirus 8 serologic tests: HHV-8 Interlaboratory Collaborative Group
19. Sexual transmission and the natural history of human herpesvirus 8 infection
20. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma
21. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma
22. Relationship of human herpesvirus 8 peripheral blood virus load and Kaposi's sarcoma clinical stage
23. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients
24. Exacerbations of clinical symptoms in human immuno-deficiency virus type 1-infected patients with multicentric Castleman's disease are associated with a high increase in Kaposi's sarcoma herpesvirus DNA load in peripheral blood mononuclear cells
25. Impaired CTL recognition of cells latently infected with Kaposi's sarcoma-associated herpes virus